Pfizer Ltd. — Regulatory Filings 2020

Oct 22, 2020

Limited

The Capital, 1802 / 1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

October 22, 2020

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Dalal Street, Fort Plot No. C/1, G Block Mumbai - 400 001 Bandra-Kurla Complex, Bandra (E) Scrip Code: 500680 Mumbai - 400 051 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Board Meeting for the Unaudited Financial Results for the quarter and half year ended September 30, 2020.

Ref: Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, November 2, 2020, inter alia , to consider and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2020.

Pursuant to the “Pfizer Limited – Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders”, the Trading Window of the Company was closed from Wednesday, September 30, 2020 (close of business) till 48 hours after the results are made public on November 2, 2020.

We request you to kindly take the same on record.

Thanking you,

Yours truly,

For Pfizer Limited

==> picture [105 x 52] intentionally omitted <==

Prajeet Nair Company Secretary

Cc: National Securities Depository Limited (NSDL) Central Depository Services (India) Limited (CDSL) KFin Technologies Private Limited

CIN: L24231MH1950PLC008311 contactus.india@pfizer.com www.pfizerindia.com